Nanotechnology based advanced therapeutic strategies for targeting interleukins in chronic respiratory diseases

MS Hussain, P Sharma, DS Dhanjal, N Khurana… - Chemico-biological …, 2021 - Elsevier
Both communicable and non-communicable chronic respiratory conditions have accorded
for suffering of millions of people of all ages and stated to be leading cause of death …

SARS-CoV-2 (COVID-19) adhesion site protein upregulation in small airways, type 2 pneumocytes, and alveolar macrophages of smokers and COPD–possible …

SJ Brake, MS Eapen, KD McAlinden… - … Journal of Chronic …, 2022 - Taylor & Francis
Background Smokers and patients with COPD are highly susceptible to SARS-CoV-2
infection, leading to severe COVID-19. Methods This cross-sectional study involved resected …

Angiotensin-converting enzyme 2 (Ace2), transmembrane peptidase serine 2 (Tmprss2), and furin expression increases in the lungs of patients with idiopathic …

W Lu, MS Eapen, GK Singhera, J Markos… - Journal of clinical …, 2022 - mdpi.com
We previously reported higher ACE2 levels in smokers and patients with COPD. The current
study investigates if patients with interstitial lung diseases (ILDs) such as IPF and LAM have …

Angiotensin converting enzyme 2 level and its significance in COVID‐19 and other diseases patients

DD Kamthe, SD Sarangkar, MS Dalvi… - European Journal of …, 2023 - Wiley Online Library
Background Angiotensin‐converting enzyme 2 (ACE2) expressions and its modulation are
of great interest as being a key receptor for severe acute respiratory syndrome coronavirus 2 …

Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy

S Paduano, M Granata, S Turchi, A Modenese… - Antibodies, 2023 - mdpi.com
Factors associated with SARS-CoV-2 infection risk are still debated. This case–control study
aims to investigate the possible relationship between SARS-CoV-2 infection, evaluated …

Therapeutic modalities for asthma, COPD, and pathogenesis of COVID-19: insights from the special issue

SS Sohal - Journal of Clinical Medicine, 2022 - mdpi.com
JCM | Free Full-Text | Therapeutic Modalities for Asthma, COPD, and Pathogenesis of COVID-19:
Insights from the Special Issue Next Article in Journal Myocardial Injuries in COVID-19: More …

Some features of the coronavirus infection course in bronchial asthma patients

MA Kharitonov, YS Burkova… - Bulletin of the …, 2022 - journals.eco-vector.com
The outbreak of a new coronavirus infection was officially recognized by the World Health
Organization as a global pandemic since March 11, 2020. The pandemic is currently …

Туберкулез и болезни легких

АА ВИЗЕЛЬ, ИЮ ВИЗЕЛЬ, МК САГЬДИЕВА… - … И БОЛЕЗНИ ЛЕГКИХ …, 2022 - elibrary.ru
Представлен анализ 46 публикаций, посвященных применению ИГКС при COVID-19.
Представлены как результаты исследований, так и их обсуждение специалистами …

Применение ингаляционных глюкокортикостероидов (ИГКС) во время пандемии COVID-19

АА Визель, ИЮ Визель, МК Сагьдиева… - … и болезни легких, 2022 - tibl-journal.com
Аннотация Представлен анализ 46 публикаций, посвященных применению ИГКС при
COVID-19. Представлены как результаты исследований, так и их обсуждение …

[HTML][HTML] The Use of Inhaled Glucocorticosteroids (ICS) during the COVID-19 Pandemic

AA Vizel, IY Vizel, MK Sagdieva… - Tuberculosis and Lung …, 2022 - tibl-journal.com
The article analyzes 46 publications on the use of ICS for COVID-19. Both research results
and their discussion by specialists are presented. The expediency of continuing basic …